image

The best stocks to buy since 1993

Our latest issue will be released in 4 days, don't miss out!

Staffline - Sells PeoplePlus and initiates buyback

March 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • STAF
  • Price:
  • 33p
There’s been a striking development from Staffline, which has announced the sale of its non core workplace training and employability business, PeoplePlus, for net cash proceeds of £6.9m including a £2m earnout due later this year. PeoplePlus has experienced delays in bid decisions for its contract pipeline following the UK general election and generated a pretax profit of £1.3m in FY24 but was forecast to only make £0.3m this year, so it looks an attractive exit. The cash proceeds bolsters Staffline’s already strong net cash position, which at the end of December was £9.7m. It has therefore also announced a whopping new £7.5m share buyback. On a continuing operations basis, Zeus has upgraded EPS by 2% to 3.1p this year and by 12% ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe